Yeol-Hong Kim
Förmögenhet: 480 797 $ per 2026-09-30
Förmögenhet: 480 797 $ per 2026-09-30
Dr. Yeol-Hong Kim is a Co-President, Executive Director, Head-R&D at Yuhan Corp.
He is on the Board of Directors at ProGen Co., Ltd., Immuneoncia Therapeutics, Inc. and Yuhan Corp.
Dr. Kim was previously employed as a Non-Executive Director by Aprilbio Co. Ltd.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
YUHAN CORPORATION 0,01 % | 2026-10-01 | 8 939 ( 0,01 % ) | 480 797 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| YUHAN CORPORATION | President | 2024-03-15 |
| PROGEN CO., LTD. | Direktör/Styrelseledamot | 2024-03-28 |
| IMMUNEONCIA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-12-26 |
| Företag | Position | Slut |
|---|---|---|
| APRILBIO CO.,LTD. | Direktör/Styrelseledamot | 2024-10-31 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Yuhan Corp.
Yuhan Corp. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and marketing of pharmaceutical products | Health Technology |
Aprilbio Co. Ltd.
Aprilbio Co. Ltd. BiotechnologyHealth Technology Operates as a drug development bio company | Health Technology |
Immuneoncia Therapeutics, Inc.
Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients | Health Technology |
Progen Co., Ltd.
Progen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medical sciences and pharmacy products | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån